糖尿病心肌病进展由miR122-5p触发并涉及细胞外基质:一项5年前瞻性研究
该5年纵向研究对59例2型糖尿病男性患者和20例非糖尿病年龄匹配对照进行心脏磁共振(CMR) tagging及代谢和分子评估,发现糖尿病患者心室质量增加、应变恶化而扭转不变,收缩达峰时间及舒张早期回弹速率降低,循环miR122-5p上调,网络分析预测其靶向MMP-16、MMP-2及其调节因子。
要点
- 2型糖尿病患者5年内左室质量指数增加(ΔLVMi=13.47±29.66 g/m2,p=0.014),应变恶化(Δσ=1.52±3.85%,p=0.033)而扭转不变。
- 收缩达峰时间缩短(ΔTtP=-35.18±28.81 ms,p<0.001),舒张早期回弹速率降低(ΔRR=-20.01±19.07 s-1,p<0.001),射血分数和代谢参数无变化。
- 循环miR122-5p上调,网络分析预测其靶向MMP-16、MMP-2及TIMP,db/db小鼠和体外实验显示miR122-5p通过调节MMP-2影响细胞外基质。
核心结论
- 糖尿病心肌病发病5年内,心脏肥厚增加伴随应变进行性受损、扭转代偿作用耗竭及黏弹性收缩动力学改变。
- 这些变化独立于血糖控制,并与靶向细胞外基质的特定microRNA上调平行。
研究设计与样本
- 5年纵向研究,纳入CECSID试验(NCT00692237)中的2型糖尿病男性患者59例,与非糖尿病年龄匹配对照20例比较。
- 基线和5年随访时进行带tagging的心脏磁共振(CMR)以及代谢和分子评估。
关键影像表现/征象
- 纵向CMR tagging显示2型糖尿病男性心室质量增加(ΔLVMi=13.47±29.66 g/m2;p=0.014),舒张末期容积呈边缘性增加(ΔEDVi=5.16±14.71 ml/m2;p=0.056)。
- 心肌应变恶化(Δσ=1.52±3.85%;p=0.033),而扭转不变(Δθ=0.24±4.04°;p=0.737),揭示应变与扭转之间适应性平衡丧失。
- 收缩动力学显示收缩达峰时间缩短(ΔTtP=-35.18±28.81 ms;p<0.001)和舒张早期回弹速率降低(ΔRR=-20.01±19.07 s-1;p<0.001)。
- 射血分数和代谢参数无变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to follow the long-term progression of diabetic cardiomyopathy by combining cardiac magnetic resonance (CMR) and molecular analysis.
BACKGROUND: The evolution of diabetic cardiomyopathy to heart failure affects patients'morbidity and mortality. CMR is the gold standard to assess cardiac remodeling, but there is a lack of markers linked to the mechanism of diabetic cardiomyopathy progression.
METHODS: Five-year longitudinal study on patients with type 2 diabetes mellitus (T2DM) enrolled in the CECSID (Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes) trial compared with nondiabetic age-matched controls. CMR with tagging together with metabolic and molecular assessments were performed at baseline and 5-year follow-up.
RESULTS: A total of 79 men (age 64 ± 8 years) enrolled, comprising 59 men with T2DM compared with 20 nondiabetic age-matched controls. Longitudinal CMR with tagging showed an increase in ventricular mass (ΔLVMi = 13.47 ± 29.66 g/m2; p = 0.014) and a borderline increase in end-diastolic volume (ΔEDVi = 5.16 ± 14.71 ml/m2; p = 0.056) in men with T2DM. Cardiac strain worsened (Δσ = 1.52 ± 3.85%; p = 0.033) whereas torsion was unchanged (Δθ = 0.24 ± 4.04°; p = 0.737), revealing a loss of the adaptive equilibrium between strain and torsion. Contraction dynamics showed a decrease in the systolic time-to-peak (ΔTtP = -35.18 ± 28.81 ms; p < 0.001) and diastolic early recoil-rate (ΔRR = -20.01 ± 19.07 s-1; p < 0.001). The ejection fraction and metabolic parameters were unchanged. Circulating miR microarray revealed an up-regulation of miR122-5p. Network analysis predicted the matrix metalloproteinases (MMPs) MMP-16 and MMP-2 and their regulator (tissue inhibitors of metalloproteinases) as targets. In db/db mice we demonstrated that miR122-5p expression is associated with diabetic cardiomyopathy, that in the diabetic heart is overexpressed, and that, in vitro, it regulates MMP-2. Finally, we demonstrated that miR122-5p overexpression affects the extracellular matrix through MMP-2 modulation.
CONCLUSIONS: Within 5 years of diabetic cardiomyopathy onset, increasing cardiac hypertrophy is associated with progressive impairment in strain, depletion of the compensatory role of torsion, and changes in viscoelastic contraction dynamics. These changes are independent of glycemic control and paralleled by the up-regulation of specific microRNAs targeting the extracellular matrix. (Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes [CECSID]; NCT00692237).
引用
- Pofi R, Giannetta E, Galea N, et al. Diabetic Cardiomiopathy Progression is Triggered by miR122-5p and Involves Extracellular Matrix: A 5-Year Prospective Study. JACC Cardiovasc Imaging. 2020. PMID: 33221242. doi:10.1016/j.jcmg.2020.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。